Journal Mobile Options
Table of Contents
Vol. 89, No. 5, 2011
Issue release date: October 2011
Stereotact Funct Neurosurg 2011;89:311–317
(DOI:10.1159/000329365)

Abnormal T2-Weighted MRI Signal Surrounding Leads in a Subset of Deep Brain Stimulation Patients

Englot D.J. · Glastonbury C.M. · Larson P.S.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background: Deep brain stimulation (DBS) surgery is a common treatment option for numerous neurological disorders. However, it is not without potential complications, such as hemorrhage and infection. Interestingly, we have observed several instances of abnormal T2-weighted signal hyperintensity surrounding DBS leads on postoperative MRI that are not associated with hemorrhage or infection. Methods: To better characterize the incidence and timing associated with this finding, we retrospectively reviewed postoperative imaging for all DBS implants performed over 9 years at one institution. Results and Conclusions: Fifteen instances of T2 signal hyperintensity surrounding DBS leads on postoperative MRI scans were observed across 239 implants (6.3% incidence) in 133 patients. The signal characteristics were most consistent with vasogenic edema, possibly representing an inflammatory response. The finding was typically unilateral, even in patients with simultaneous bilateral lead implants. Most affected patients were asymptomatic, although 3 were symptomatic and 1 experienced marked gait instability that was treated with steroids. T2 signal abnormality was seen more commonly in scans obtained 3 or more days after surgery than in those collected immediately postoperatively. No differences in age, anatomical target, diagnosis, or number of microelectrode passes were noted between patients with or without T2 signal. Further research will be needed to explain this curious neuroimaging finding, and to rule out cause for clinical concern.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Papavassiliou E, Rau G, Heath S, Abosch A, Barbaro NM, Larson PS, Lamborn K, Starr PA: Thalamic deep brain stimulation for essential tremor: relation of lead location to outcome. Neurosurgery 2004;54:1120–1130.
  2. Lozano AM, Snyder BJ: Deep brain stimulation for parkinsonian gait disorders. J Neurol 2008;255(suppl 4):30–31.

    External Resources

  3. Jankovic J: Treatment of dystonia. Lancet Neurol 2006;5:864–872.
  4. Levy R, Deer TR, Henderson J: Intracranial neurostimulation for pain control: a review. Pain Physician 2010;13:157–165.
  5. Larson PS: Deep brain stimulation for psychiatric disorders. Neurotherapeutics 2008;5:50–58.
  6. Jobst BC, Darcey TM, Thadani VM, Roberts DW: Brain stimulation for the treatment of epilepsy. Epilepsia 2010;51(suppl 3):88–92.

    External Resources

  7. Sen AN, Campbell PG, Yadla S, Jallo J, Sharan AD: Deep brain stimulation in the management of disorders of consciousness: a review of physiology, previous reports, and ethical considerations. Neurosurg Focus 2010;29:E14.

    External Resources

  8. Sillay KA, Sani S, Starr PA: Deep brain stimulation for medically intractable cluster headache. Neurobiol Dis 2010;38:361–368.

    External Resources

  9. Beric A, Kelly PJ, Rezai A, Sterio D, Mogilner A, Zonenshayn M, Kopell B: Complications of deep brain stimulation surgery. Stereotact Funct Neurosurg 2001;77:73–78.
  10. Binder DK, Rau GM, Starr PA: Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders. Neurosurgery 2005;56:722–732.
  11. Sillay KA, Larson PS, Starr PA: Deep brain stimulator hardware-related infections: incidence and management in a large series. Neurosurgery 2008;62:360–367.
  12. Richardson RM, Ostrem JL, Starr PA: Surgical repositioning of misplaced subthalamic electrodes in Parkinson’s disease: location of effective and ineffective leads. Stereotact Funct Neurosurg 2009;87:297–303.
  13. Fernandez FS, Alvarez Vega MA, Antuna Ramos A, Fernandez Gonzalez F, Lozano Aragoneses B: Lead fractures in deep brain stimulation during long-term follow-up. Parkinsons Dis 2010;2010:409356.
  14. Larson PS, Richardson RM, Starr PA, Martin AJ: Magnetic resonance imaging of implanted deep brain stimulators: experience in a large series. Stereotact Funct Neurosurg 2008;86:92–100.
  15. Fraix V, Chabardes S, Krainik A, Seigneuret E, Grand S, Le Bas JF, Krack P, Benabid AL, Pollak P: Effects of magnetic resonance imaging in patients with implanted deep brain stimulation systems. J Neurosurg 2010;113:1242–1245.

    External Resources

  16. Starr PA, Christine CW, Theodosopoulos PV, Lindsey N, Byrd D, Mosley A, Marks WJ Jr: Implantation of deep brain stimulators into the subthalamic nucleus: technical approach and magnetic resonance imaging-verified lead locations. J Neurosurg 2002;97:370–387.
  17. Schrader B, Hamel W, Weinert D, Mehdorn HM: Documentation of electrode localization. Mov Disord 2002;17(suppl 3):S167–S174.
  18. Ryu SI, Romanelli P, Heit G: Asymptomatic transient MRI signal changes after unilateral deep brain stimulation electrode implantation for movement disorder. Stereotact Funct Neurosurg 2004;82:65–69.
  19. Huk WJ, Gademann G: Magnetic resonance imaging (MRI): method and early clinical experiences in diseases of the central nervous system. Neurosurg Rev 1984;7:259–280.
  20. Go KG: The normal and pathological physiology of brain water. Adv Tech Stand Neurosurg 1997;23:47–142.
  21. Morishita T, Foote KD, Wu SS, Jacobson CE 4th, Rodriguez RL, Haq IU, Siddiqui MS, Malaty IA, Hass CJ, Okun MS: Brain penetration effects of microelectrodes and deep brain stimulation leads in ventral intermediate nucleus stimulation for essential tremor. J Neurosurg 2010;112:491–496.

    External Resources

  22. Derrey S, Lefaucheur R, Chastan N, Gerardin E, Hannequin D, Desbordes M, Maltete D: Alleviation of off-period dystonia in Parkinson disease by a microlesion following subthalamic implantation. J Neurosurg 2010; 112:1263–1266.

    External Resources

  23. Mann JM, Foote KD, Garvan CW, Fernandez HH, Jacobson CE 4th, Rodriguez RL, Haq IU, Siddiqui MS, Malaty IA, Morishita T, Hass CJ, Okun MS: Brain penetration effects of microelectrodes and DBS leads in STN or GPi. J Neurol Neurosurg Psychiatry 2009;80:794–797.
  24. Henderson JM, Pell M, O’Sullivan DJ, McCusker EA, Fung VS, Hedges P, Halliday GM: Postmortem analysis of bilateral subthalamic electrode implants in Parkinson’s disease. Mov Disord 2002;17:133–137.

    External Resources

  25. Medtronic, Inc: Lead Kit for Deep Brain Stimulation Implant Manual. Minneapolis, Medtronic Inc, 2008.
  26. Hooper S, Cameron T: Neurotoxicity screening test for deep brain stimulation leads. J Biomater Sci Polym Ed 2007;18:1309–1320.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50